Workflow
UFP Technologies(UFPT) - 2024 Q4 - Annual Results
UFPTUFP Technologies(UFPT)2025-02-25 21:10

Financial Performance - UFP Technologies reported 2024 net income of 59.0million,a31.359.0 million, a 31.3% increase from 44.9 million in 2023, with adjusted net income growing 32.5% to 67.6million[2].Netsalesfor2024reached67.6 million[2]. - Net sales for 2024 reached 504.4 million, up 26.1% from 400.1millionin2023,whilefourthquartersalesincreased41.9400.1 million in 2023, while fourth-quarter sales increased 41.9% to 144.1 million compared to 101.5millioninQ42023[3][5].Thecompanysgrossmarginimprovedto29.2101.5 million in Q4 2023[3][5]. - The company's gross margin improved to 29.2% in Q4 2024 from 25.7% in Q4 2023, and for the full year, it increased to 29.1% from 28.1%[5]. - Adjusted operating income for Q4 2024 rose 84.0% to 26.0 million, while full-year adjusted operating income increased 40.4% to 92.3million[9].UFPTechnologiesexperiencedorganicgrowthof6.792.3 million[9]. - UFP Technologies experienced organic growth of 6.7% in Q4 and 8.5% for the full year[4]. - MedTech sales surged 48.6% in Q4 to 132.7 million, with full-year MedTech sales up 30.2% to 450.8million[5].CashFlowandAssetsCashandcashequivalentsincreasedto450.8 million[5]. Cash Flow and Assets - Cash and cash equivalents increased to 13.45 million in 2024 from 5.26millionin2023,whiletotalassetsroseto5.26 million in 2023, while total assets rose to 628.99 million from 404.14million[10].Totalliabilitiesincreasedto404.14 million[10]. - Total liabilities increased to 286.24 million in 2024 from 118.05millionin2023,withlongtermdebtrisingto118.05 million in 2023, with long-term debt rising to 176.88 million from 28.00 million[10]. Operating Expenses - Adjusted SG&A (Non-GAAP) for Q4 2024 was 16,094, compared to 12,020inQ42023,representinganincreaseof33.312,020 in Q4 2023, representing an increase of 33.3%[16]. - Total SG&A (GAAP) for the twelve months ended December 31, 2024, was 62,218, up from 50,889in2023,anincreaseof22.350,889 in 2023, an increase of 22.3%[16]. Earnings and EBITDA - Adjusted net income (Non-GAAP) for Q4 2024 was 19,163, up from 12,640inQ42023,reflectingagrowthof51.912,640 in Q4 2023, reflecting a growth of 51.9%[19]. - Adjusted net income per diluted share (Non-GAAP) increased to 2.46 in Q4 2024 from 1.64inQ42023,ariseof50.01.64 in Q4 2023, a rise of 50.0%[19]. - EBITDA (Non-GAAP) for Q4 2024 reached 27,133, compared to 15,607inQ42023,markingasignificantincreaseof73.815,607 in Q4 2023, marking a significant increase of 73.8%[21]. - Adjusted EBITDA (Non-GAAP) for the twelve months ended December 31, 2024, was 107,321, up from 77,167inthepreviousyear,anincreaseof39.177,167 in the previous year, an increase of 39.1%[21]. - Net income (GAAP) for Q4 2024 was 16,375, compared to 11,607inQ42023,representinganincreaseof41.011,607 in Q4 2023, representing an increase of 41.0%[19]. Strategic Initiatives - The company is expanding operations in the Dominican Republic to support new business and increased demand, necessitating additional plant and equipment investments[4]. - UFP Technologies plans to launch two major programs in the second half of 2025 and is actively pursuing acquisitions to enhance its platform[4]. - Acquisition costs for the twelve months ended December 31, 2024, amounted to 2,520, compared to 0in2023[19].AmortizationofintangibleassetsforthetwelvemonthsendedDecember31,2024,was0 in 2023[19]. - Amortization of intangible assets for the twelve months ended December 31, 2024, was 6,727, up from $4,403 in 2023, an increase of 52.8%[19]. Shareholder Information - The weighted average diluted common shares outstanding increased slightly to 7,794 in Q4 2024 from 7,712 in Q4 2023[19].